Readystate Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$676K Buy
+7,800
New +$747K 0.03% 522
2025
Q2
Sell
-21,300
Closed -$1.91M 809
2025
Q1
$1.91M Buy
21,300
+700
+3% +$62.6K 0.06% 329
2024
Q4
$1.65M Sell
20,600
-183,500
-90% -$15.9M 0.05% 343
2024
Q3
$18.4M Buy
204,100
+195,000
+2,143% +$16.4M 0.34% 49
2024
Q2
$716K Sell
9,100
-167,300
-95% -$13.7M 0.02% 408
2024
Q1
$15.4M Buy
176,400
+175,100
+13,469% +$14.9M 0.22% 85
2023
Q4
$107K Buy
+1,300
New +$99.1K ﹤0.01% 584
2023
Q2
Sell
-4,000
Closed -$322K 360
2023
Q1
$322K Buy
+4,000
New +$326K 0.03% 209

Other funds holding MDT

Readystate Asset Management's MDT Position: Q1 2026 in Review

Readystate Asset Management opened a new position in Medtronic (MDT) in Q1 2026: 2,959 shares worth $256K. The stake represents 0.01% of the portfolio and ranks #721 among its holdings.

2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Readystate Asset Management held 2,959 shares of Medtronic worth $256K as of Q1 2026.
  • Medtronic was a new Readystate Asset Management position in Q1 2026.
  • Medtronic made up 0.01% of Readystate Asset Management's portfolio in Q1 2026, its #721 holding.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Readystate Asset Management's 13F filing for Q1 2026, filed 15 May 2026.